Epidemiology of Parkinson's disease

被引:411
作者
Tanner, CM
Goldman, SM
机构
[1] Parkinson's Institute, Sunnyvale, CA 94089
关键词
D O I
10.1016/S0733-8619(05)70259-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease (PD) currently affects at least 500,000 people in the United States alone. Its prevalence is expected to triple in the next 50 years with the aging of the population. Its prevalence varies widely in community-based studies, possibly reflecting differences in risk factors among the populations studied as well as differences among study methods. Heredity, race, and gender may be risk factors. Many case-control studies show increased risk in association with rural residence, farming, and herbicide or pesticide exposure, and a decreased risk with antioxidant vitamin intake and cigarette smoking; however, the significance of these associations in regard to disease etiology is unknown.
引用
收藏
页码:317 / +
页数:1
相关论文
共 161 条
[71]   EPIDEMIOLOGIC STUDIES OF PARKINSONS DISEASE .1. SMOKING AND PARKINSONS DISEASE - SURVEY AND EXPLANATORY HYPOTHESIS [J].
KESSLER, II ;
DIAMOND, EL .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1971, 94 (01) :16-&
[72]   EPIDEMIOLOGIC STUDIES OF PARKINSONS DISEASE .2. HOSPITAL-BASED SURVEY [J].
KESSLER, II .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1972, 95 (04) :308-&
[73]   EPIDEMIOLOGIC STUDIES OF PARKINSONS DISEASE .3. COMMUNITY-BASED SURVEY [J].
KESSLER, II .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1972, 96 (04) :242-&
[74]   L-DOPA-RESPONSIVE MOVEMENT DISORDER CAUSED BY NOCARDIA-ASTEROIDES LOCALIZED IN THE BRAINS OF MICE [J].
KOHBATA, S ;
BEAMAN, BL .
INFECTION AND IMMUNITY, 1991, 59 (01) :181-191
[75]  
KOHBATA S, 1993, ADV NEUROL, V60, P355
[76]   ENVIRONMENTAL RISK-FACTORS IN PARKINSONS-DISEASE [J].
KOLLER, W ;
VETEREOVERFIELD, B ;
GRAY, C ;
ALEXANDER, C ;
CHIN, T ;
DOLEZAL, J ;
HASSANEIN, R ;
TANNER, C .
NEUROLOGY, 1990, 40 (08) :1218-1221
[77]  
KOLLER WC, 1987, HDB PARKINSONS DISEA, P51
[78]  
KONDO I, 1993, ADV NEUROL, V60, P338
[79]  
KONDO K, 1973, MAYO CLIN PROC, V48, P465
[80]  
Kurland L. T, 1958, PATHOGENESIS TREATME, P5